Stay updated on Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.

Latest updates to the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSystem updates show Revision: v3.4.2 added and prior notices about funding and operating status (Revision: v3.4.1) present in the deletions. These changes relate to site maintenance and do not modify the trial record details, outcomes, or recruitment information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice and updated the page to Revision: v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedFooter/UI updates add a 'Show glossary' option, adjust the 'No FEAR Act Data' label capitalization, and update the site revision from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check64 days agoChange DetectedFooter updates include the addition of Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link as well as the Revision: v3.3.2 reference. These changes do not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page revision changed from v3.3.1 to v3.3.2; no study content or critical elements were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.